Not yet evaluated
About the journal
Pharmaceutical Patent Analyst is a journal published by Future Science Ltd in United Kingdom. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Future Science Ltd
- ISSN
- 2046-8954 · 2046-8962
- Country
- United Kingdom
- Access
- Not open access / not declared
- Official website
- http://www.future-science.com/loi/ppa
Index listings
- PUBMED · 2018-03-01
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2024
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
552
Last recorded publication year
2024
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
26
i10-index
94
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 71%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity1
- Source type
- journal
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Intellectual Property and Patents
- Intellectual Property and Patents
- Intellectual Property and Patents
- Pharmaceutical Economics and Policy
- Intellectual Property Law
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Biomedical Ethics and Regulation
Show all subjects (75)
- Biomedical Ethics and Regulation
- Science, Research, and Medicine
- Health Systems, Economic Evaluations, Quality of Life
- Biosimilars and Bioanalytical Methods
- Health Systems, Economic Evaluations, Quality of Life
- Biosimilars and Bioanalytical Methods
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Cancer Research and Treatments
- Cancer Research and Treatments
- Biotechnology and Related Fields
- Biotechnology and Related Fields
- Ubiquitin and proteasome pathways
- Computational Drug Discovery Methods
- Advanced Drug Delivery Systems
- Computational Drug Discovery Methods
- Nanoparticle-Based Drug Delivery
- Ubiquitin and proteasome pathways
- Law, AI, and Intellectual Property
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Biosimilars and Bioanalytical Methods
- Synthesis and biological activity
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- Computational Drug Discovery Methods
- Cancer, Hypoxia, and Metabolism
- Biochemical and Molecular Research
- Biochemical and Molecular Research
- Cancer, Hypoxia, and Metabolism
- Innovation Policy and R&D
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Innovation Policy and R&D
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery
- Monoclonal and Polyclonal Antibodies Research
- Science, Research, and Medicine
- ATP Synthase and ATPases Research
- Cancer Immunotherapy and Biomarkers
- Click Chemistry and Applications
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Law, AI, and Intellectual Property
- Click Chemistry and Applications
- ATP Synthase and ATPases Research
- Educational Robotics and Engineering
- Educational Robotics and Engineering
- Science, Research, and Medicine
- Human auditory perception and evaluation
- Diverse Scientific and Economic Studies
- Law, AI, and Intellectual Property
- scientometrics and bibliometrics research
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
- Alzheimer's disease research and treatments
- Drug Solubulity and Delivery Systems
- Receptor Mechanisms and Signaling
- Immunotherapy and Immune Responses
- Inhalation and Respiratory Drug Delivery
- Cholinesterase and Neurodegenerative Diseases
- Ion channel regulation and function
- Advancements in Transdermal Drug Delivery
- Pain Mechanisms and Treatments
- Diabetes Treatment and Management
- Radiopharmaceutical Chemistry and Applications
- Neuroscience and Neuropharmacology Research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ